Paraneoplastic cerebellar degeneration in a patient with pseudomyxoma peritonei and breast cancer: Case report and literature review

In Vivo

Volumn 23, Issue 5, 2009, Pages 835-838

  Ardavanis, Alexandros ^a   Sykoutri, Despina ^a   Kountourakis, Panteleimon ^a   Doufexis, Dimitrios ^a   Korkolis, Dimitrios ^a   Tzerbini, Helen ^a   Skarlatos, Ioannis ^a   Mosa, Eftychia ^a   Rigatos, Gerasimos ^a  

^a SAINT SAVVAS HOSPITAL   (Greece)

Author keywords

Antineuronal antibody; Breast cancer; Paraneoplastic neurological syndrome; Pseudomyxoma peritonei

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; OXALIPLATIN; PACLITAXEL; STEROID; TRASTUZUMAB;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER REGRESSION; CANCER SURGERY; CASE REPORT; CEREBELLUM DEGENERATION; CYTOREDUCTIVE SURGERY; FATALITY; FEMALE; HUMAN; PARANEOPLASTIC SYNDROME; PERITONEUM PSEUDOMYXOMA; URETER OBSTRUCTION;

EID: 70350048865     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Altaha R and Abraham J: Paraneoplastic neurologic syndrome associated with occult breast cancer: A case report and review of literature. Breast J 9: 417-419, 2003. (Pubitemid 37158919)
2. Gatti G, Simsek S, Kurne A, Zurrida S, Naninato P, Veronesi P, Frasson A, Millen E, Rososchansky J and Luini A: Paraneoplastic neurological disorders in breast cancer. Breast 12: 203-207, 2003. (Pubitemid 36665517)
3. Darnell RB and Posner JB: Mechanisms of disease: paraneoplastic syndromes involving the nervous system. N Engl J Med 349: 1543-1554, 2003.
4. Rojas-Marcos I, Rosseau A, Keime-Guibert F, Reñé R, Cartalat-Carel S, Delattre JY and Graus F: Spectrum of paraneoplastic neurologic disorders in women with breast and gynaecologic cancer. Medicine 82: 216-223, 2003. (Pubitemid 36578710)
5. Kawasoe T, Yamamoto Y, Okumura Y and Iwase H: A case report of paraneoplastic neurological syndrome associated with occult breast cancer. Breast Cancer 13: 202-204, 2006.
6. Van Ruth S, Acherman YIZ, van de Vijver MJ Hart AA, Verwaal VJ and Zoetmulder FA: Pseudomyxoma peritonei: a review of 62 cases. Eur J Surg Oncol 29: 682-688, 2003.
7. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH and Shmookler BM: Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to 'pseudomyxoma peritonei'. Am J Surg Pathol 19: 1390-1408, 1995.
8. Croteau D, Owainati A, Dalmau J and Roqers LR: Response to cancer therapy in a patient with a paraneoplastic choreiform disorder. Neurology 57: 719-722, 2001. (Pubitemid 32783009)
9. Vigliani MC, Palmucci L, Polo P Mutani R, Schiffer D, De Luca S and De Zan A: Paraneoplastic opsoclonus-myoclonus associated with renal cell carcinoma and responsive to tumour ablation. J Neurol Neurosurg Psychiatry 70: 814-815, 2001. (Pubitemid 32554221)
10. Carmignani CP, Hampton R, Sugarbaker CE, Chang D and Sugarbaker PH: Utility of CEA and CA19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix. J Surg Oncol 87: 162-166, 2004. (Pubitemid 39167382)
11. Smeenk RM, Verwaal VJ and Zoetmulder FA: Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei - a report of 103 procedures. Eur J Surg Oncol 32: 186-190, 2006.
12. O'Connell JT, Tomlinson JS, Roberts AA McGonigle KF and Barsky SH: Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells. Am J Pathol 161: 551-564, 2002.